Novel regulators of PD-L1 expression in cancer: CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors.

Thumbnail
View/Open
Date
2017-12-01
Author
Imamovic, Denira
Vranic, Semir
Metadata
Show full item record
Abstract
CMTM6 and CMTM4-a new avenue to enhance the therapeutic benefits of immune checkpoint inhibitors
DOI/handle
http://dx.doi.org/10.21037/atm.2017.09.32
http://hdl.handle.net/10576/11469
Collections